Sihuan Pharmaceutical Group has a diversified portfolio of products which cover the top five medical therapeutic areas in the PRC:  cardio-cerebral vascular system, nervous system, metabolism, anti-infective, and oncology. We currently have over 100 prescription drugs in different formulations and dosages, over 40 of which are cardio-cerebral vascular products.
Commodities: Kelinao/Anjieli
Generic Name:CinepazideMaleateInjection
Indications:• Cerebrovascular diseases: cerebral arteriosclerosis, transient ischemic attack, cerebral thrombosis, sequelae of subarachnoid hemorrhage, intracerebral hemorrhage, and traumatic cerebral injuries
• Cardiovascular diseases: coronary artery diseases, angina pectoris; combination therapies with other medicines are necessary for myocardial infarction
• Peripheral vascular diseases: lower extremity arteriosclerosis, thromboangiitis obliterans, arteritis, Raynaud’s disease
Mechanisms of action:• Ca2+ blocker:dilates vessels and restores blood flow to the ischemic regions
• Stimulation of endogenous adenosine effects: blocks pathological cascades involved in the stroke at various pathways by inhibiting the metabolism and uptake of adenosine, which is an endogenous protector secreted in response to ischemia and hypoxia, thereby, protecting neurons from the ischemic injury
• Improvements of hemorheological parameters:enhances the red blood cell deformability and reduces blood viscosity, thereby improving microcirculation